Clinical Trial Update: Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating FKB238 in combination with Avastin for advanced/recurrent non-squamous non-small cell lung cancer has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Non-small-cell Lung
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• FKB238

Snippet

Sponsor: Centus Biotherapeutics Limited | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED | Results posted: 2020-03-19